CYP2C19 and ABCB1 genetic polymorphisms correlate with the recurrence of ischemic cardiovascular adverse events after clopidogrel treatment.
J Clin Lab Anal
; 32(5): e22369, 2018 Jun.
Article
in En
| MEDLINE
| ID: mdl-29397568
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polymorphism, Genetic
/
Ticlopidine
/
Platelet Aggregation Inhibitors
/
Coronary Disease
/
Cytochrome P-450 CYP2C19
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Lab Anal
Journal subject:
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Year:
2018
Document type:
Article
Affiliation country:
China
Country of publication:
United States